ATEC Alphatec Holdings Inc

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 19, 2014

ALPHATEC HOLDINGS, INC.

(Exact Name of Registrant as Specified in its Charter)

Registrant’s telephone number, including area code: (760) 431-9286

(Former Name or Former Address, if Changed Since Last Report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

(b) On November 19, 2014, the Board of Directors (the “Board”) of Alphatec Spine, Inc. and Alphatec Holdings, Inc. (the “Company”) increased the size of the Board to ten and appointed Tom C. Davis to the Board, effective November 19, 2014. Mr. Davis qualifies as independent under the definition promulgated by NASDAQ and therefore is eligible to be a member of the Board’s Audit Committee or Nominating, Governance and Compensation Committee. The Company believes that Mr. Davis possesses specific attributes that qualify him to serve as a director of the Company, including the perspective and experience he will bring based on his prior experience as an investment banker, and his prior and current experience as a Non-Executive Chairman and a member of the board of directors of both private and publicly traded companies.

(c) Mr. Davis, age 65, currently serves as Chief Executive Officer of The Concorde Group, a private investment firm, a position he has held since March 2001. He previously served as Managing Director of Bluffview Capital, LP, an investment banking firm that he co-founded, from 2001 to 2012 and as Managing Partner of Gryphon Special Situations Fund L.P. from 2004 to 2009. He was the managing partner and head of banking and corporate finance for the Southwest division of Credit Suisse First Boston from March 1984 to February 2001. Mr. Davis also serves on the Boards of Directors of Dean Foods Company (NYSE: DF), where he also serves as the Non-Executive Chairman and where he also serves as a member of the Audit, Compensation and Executive Committees; Affirmative Insurance Holdings, Inc. (OTC: AFFM), an insurance holding company, where he serves as Chairman of the Board and as a member of the Audit, Compensation and Investment Committees; MicroDental Co., a privately-held dental laboratory network company, where he serves on the Audit and Compensation Committees; and WhiteHorse Finance, Inc. (Nasdaq: WHIF), a closed-end management investment company that targets debt investments in privately held, small-cap U.S. companies, where he serves as chairman of the Nominating and Corporate Governance Committee and is a member of the Audit Committee. Until April 2013, Mr. Davis served on the Board of Directors of Westwood Holdings Group, Inc. (NYSE: WHG), an investment management and trust services company, where he served on the Audit and Compensation Committees. He also served on the Board of Directors, including as a member of its Audit and Compensation Committees, of BioHorizons, Inc., which at the time was a privately-held dental equipment and supplies manufacturing company, until early 2014.

On November 24, 2014 the Company issued a press release announcing Mr. Davis’s appointment to the Board, a copy of which is attached hereto as Exhibit 99.1 and incorporated herein by reference.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Exhibit 99.1

FOR IMMEDIATE RELEASE

Alphatec Spine Announces Appointment of Tom C. Davis to its Board of Directors

CARLSBAD, CA, November 24, 2014 – Alphatec Holdings, Inc. (Nasdaq: ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that its board of directors has appointed Tom C. Davis as a member of the board of directors, effectively immediately. Mr. Davis has served as Chief Executive Officer of The Concorde Group, a private investment firm, since March 2001, and currently serves as the Non-Executive Chairman of the Board of Dean Foods Company (NYSE: DF).

This appointment expands the Alphatec Spine board to 10 directors. Mr. Davis is qualified as an independent director under the definition established by Nasdaq.

“I am very pleased to welcome Tom to the Alphatec Spine board of directors,” said Jim Corbett, President and Chief Executive Officer. “Tom’s 30 years of broad experience across multiple industries will add valuable perspectives to our board. We look forward to working closely with Tom and benefitting from his counsel and strategic insights as we continue our pursuit of profitable, global growth.”

Mr. Davis also serves as a member of the boards of Affirmative Insurance Holding, Inc., MicroDental Co., and Whitehorse Finance, Inc. Previously, Mr. Davis has held key executive leadership roles, including Managing Director of Bluffview Capital, LP, Managing Partner of Gryphon Special Situations Fund L.P. and Managing Partner and Head of Banking and Corporate Finance for the Southwest division of Credit Suisse First Boston. Mr. Davis received a B.S. in Aerospace Engineering from Georgia Institute of Technology and an M.B.A. from Harvard Business School. Mr. Davis also was an officer in the U.S. Navy.

Further information regarding the Company’s appointment of Tom C. Davis to its board of directors is set forth in a Current Reports on Form 8-K that was filed with the U.S. Securities and Exchange Commission (SEC) on November 24, 2014 and is available on both the SEC’s website at www.sec.gov and the Company’s website at www.alphatecspine.com.

About Alphatec Spine

Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc. (Nasdaq: ATEC), is a global provider of spinal fusion technologies. The Company’s mission is to combine innovative surgical solutions with world-class customer service to help improve outcomes and patient’s quality of life. The Company and its affiliates market products in the U.S. and internationally via a direct sales force and independent distributors.

Additional information can be found at www.alphatecspine.com.

Forward Looking Statements

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management’s current expectations and are subject to a number of risks and uncertainties that could

-more-

cause actual results to differ materially from those described in the forward-looking statements. Alphatec Spine cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors. Forward-looking statements include the Company’s ability to achieve profitable growth. The words “believe,” “will,” “should,” “expect,” “intend,” “estimate” and “anticipate,” variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. Please refer to the risks detailed from time to time in Alphatec Spine’s SEC reports, including its Annual Report Form 10-K, as well as other filings on Form 10-Q and periodic filings on Form 8-K. Alphatec Spine disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law.

CONTACT: Investor/Media Contact:

Christine Zedelmayer

Investor Relations

Alphatec Spine, Inc.

(760) 494-6610

czedelmayer@alphatecspine.com

# # #

Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Mar 2024 to Apr 2024

Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Apr 2023 to Apr 2024